Jan 31 (Reuters) - Utah Medical Products Inc UTMD.O :
* UTMD REPORTS AUDITED YEAR 2022 AND FOURTH QUARTER
FINANCIAL
PERFORMANCE
* UTAH MEDICAL PRODUCTS INC - TOTAL CONSOLIDATED 4Q 2022
UTMD
WORLDWIDE SALES WERE $661, 5.1% HIGHER THAN IN 4Q 202
* UTAH MEDICAL PRODUCTS INC - U.S. DOMESTIC SALES WERE 7%
LOWER
AND OUTSIDE U.S. SALES WERE 25% HIGHER THAN IN 4Q 2021
* UTAH MEDICAL PRODUCTS INC - DILUTED EPS IN 4Q 2022 WERE
$1.253
Source text for Eikon: ID:nGNXshhx6
Further company coverage: UTMD.O
((Reuters.Briefs@thomsonreuters.com;))